Richard Paulson's most recent trade in Karyopharm Therapeutics Inc was a trade of 236 Common Stock done at an average price of $7.1 . Disclosure was reported to the exchange on May 6, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Karyopharm Therapeutics Inc | Richard Paulson | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 7.12 per share. | 06 May 2025 | 236 | 82,503 (0%) | 0% | 7.1 | 1,680 | Common Stock |
| Karyopharm Therapeutics Inc | Richard Paulson | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 3.74 per share. | 04 Apr 2025 | 245 | 82,739 (0%) | 0% | 3.7 | 916 | Common Stock |
| Karyopharm Therapeutics Inc | Richard Paulson | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 6.29 per share. | 04 Mar 2025 | 11,694 | 82,984 (0%) | 0% | 6.3 | 73,555 | Common Stock |
| Karyopharm Therapeutics Inc | Richard Paulson | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 40,000 | 40,000 | - | - | Stock Option (right to buy) | |
| Karyopharm Therapeutics Inc | Richard Paulson | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 20,000 | 94,678 (0%) | 0% | 0 | Common Stock | |
| Karyopharm Therapeutics Inc | Richard Paulson | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 0.65 per share. | 04 Feb 2025 | 4,099 | 1,120,158 (1%) | 0% | 0.6 | 2,664 | Common Stock |
| Karyopharm Therapeutics Inc | Richard Paulson | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 0.78 per share. | 06 Jan 2025 | 4,055 | 1,124,257 (1%) | 0% | 0.8 | 3,175 | Common Stock |
| Karyopharm Therapeutics Inc | Paulson Richard | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 0.81 per share. | 04 Dec 2024 | 3,620 | 1,128,312 (1%) | 0% | 0.8 | 2,932 | Common Stock |
| Bluebird bio Inc | Richard Paulson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Nov 2024 | 49,850 | 49,850 | - | - | Stock Option (right to buy) | |
| Bluebird bio Inc | Richard Paulson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Nov 2024 | 24,900 | 29,563 (0%) | 0% | 0 | Common Stock | |
| Karyopharm Therapeutics Inc | Richard Paulson | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 0.91 per share. | 05 Nov 2024 | 3,675 | 1,131,932 (1%) | 0% | 0.9 | 3,346 | Common Stock |
| Karyopharm Therapeutics Inc | Richard Paulson | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 0.88 per share. | 04 Oct 2024 | 3,607 | 1,135,607 (1%) | 0% | 0.9 | 3,172 | Common Stock |
| Karyopharm Therapeutics Inc | Richard Paulson | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 0.72 per share. | 04 Sep 2024 | 3,667 | 1,139,214 (1%) | 0% | 0.7 | 2,647 | Common Stock |
| Karyopharm Therapeutics Inc | Richard Paulson | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 0.93 per share. | 06 Aug 2024 | 3,608 | 1,142,881 (1%) | 0% | 0.9 | 3,355 | Common Stock |
| Karyopharm Therapeutics Inc | Richard Paulson | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 0.85 per share. | 05 Jul 2024 | 3,616 | 1,146,489 (1%) | 0% | 0.9 | 3,077 | Common Stock |
| Karyopharm Therapeutics Inc | Richard Paulson | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 0.99 per share. | 04 Jun 2024 | 3,592 | 1,150,105 (1%) | 0% | 1.0 | 3,556 | Common Stock |
| Karyopharm Therapeutics Inc | Richard Paulson | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 1.13 per share. | 06 May 2024 | 3,576 | 1,153,697 (1%) | 0% | 1.1 | 4,041 | Common Stock |
| Karyopharm Therapeutics Inc | Richard Paulson | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 1.29 per share. | 04 Apr 2024 | 3,563 | 1,157,273 (1%) | 0% | 1.3 | 4,596 | Common Stock |
| Karyopharm Therapeutics Inc | Richard Paulson | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 1.30 per share. | 05 Mar 2024 | 3,573 | 1,160,836 (1%) | 0% | 1.3 | 4,645 | Common Stock |
| Karyopharm Therapeutics Inc | Richard Paulson | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 1.17 per share. | 29 Feb 2024 | 80,470 | 1,183,783 (1%) | 0% | 1.2 | 94,150 | Common |
| Karyopharm Therapeutics Inc | Richard Paulson | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 1.20 per share. | 29 Feb 2024 | 19,374 | 1,164,409 (1%) | 0% | 1.2 | 23,249 | Common |
| Karyopharm Therapeutics Inc | Paulson Richard | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2024 | 442,800 | 1,264,253 (1%) | 0% | 0 | Common Stock | |
| Karyopharm Therapeutics Inc | Paulson Richard | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 1.59 per share. | 06 Feb 2024 | 4,012 | 821,453 (1%) | 0% | 1.6 | 6,365 | Common Stock |
| Karyopharm Therapeutics Inc | Paulson Richard | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jan 2024 | 42,000 | 825,465 (1%) | 0% | 0 | Common Stock | |
| Karyopharm Therapeutics Inc | Richard Paulson | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 0.82 per share. | 04 Jan 2024 | 4,114 | 783,465 (1%) | 0% | 0.8 | 3,373 | Common Stock |
| Karyopharm Therapeutics Inc | Richard Paulson | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 0.79 per share. | 04 Dec 2023 | 3,622 | 787,579 (1%) | 0% | 0.8 | 2,861 | Common Stock |
| Karyopharm Therapeutics Inc | Richard Paulson | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 1.72 per share. | 07 Aug 2023 | 3,722 | 802,018 (1%) | 0% | 1.7 | 6,402 | Common Stock |
| Karyopharm Therapeutics Inc | Richard Paulson | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 1.72 per share. | 05 Jul 2023 | 3,538 | 805,740 (1%) | 0% | 1.7 | 6,085 | Common Stock |
| Karyopharm Therapeutics Inc | Richard Paulson | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 2.24 per share. | 05 Jun 2023 | 3,536 | 809,278 (1%) | 0% | 2.2 | 7,922 | Common Stock |
| Karyopharm Therapeutics Inc | Richard Paulson | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 3.35 per share. | 04 May 2023 | 3,805 | 812,814 (1%) | 0% | 3.4 | 12,753 | Common Stock |
| Karyopharm Therapeutics Inc | Richard Paulson | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 3.97 per share. | 04 Apr 2023 | 3,497 | 816,619 (1%) | 0% | 4.0 | 13,883 | Common Stock |
| Bluebird bio Inc | Richard Paulson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Apr 2023 | 7,500 | 7,500 | - | - | Stock Options (Right to buy) | |
| Bluebird bio Inc | Richard Paulson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Apr 2023 | 4,663 | 4,663 (0%) | 0% | 0 | Common Stock | |
| Karyopharm Therapeutics Inc | Richard Paulson | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 3.16 per share. | 06 Mar 2023 | 3,506 | 820,116 (1%) | 0% | 3.2 | 11,079 | Common Stock |
| Karyopharm Therapeutics Inc | Richard Paulson | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2023 | 252,000 | 856,655 (1%) | 0% | 0 | Common Stock | |
| Karyopharm Therapeutics Inc | Richard Paulson | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 3.03 per share. | 28 Feb 2023 | 33,033 | 823,622 (1%) | 0% | 3.0 | 100,064 | Common Stock |
| Karyopharm Therapeutics Inc | Richard Paulson | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 3.40 per share. | 06 Feb 2023 | 3,950 | 604,655 (0%) | 0% | 3.4 | 13,430 | Common Stock |
| Karyopharm Therapeutics Inc | Richard Paulson | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 3.27 per share. | 04 Jan 2023 | 3,922 | 608,605 (0%) | 0% | 3.3 | 12,825 | Common Stock |
| Karyopharm Therapeutics Inc | Richard Paulson | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 5.17 per share. | 05 Dec 2022 | 3,490 | 612,527 (0%) | 0% | 5.2 | 18,043 | Common Stock |
| Karyopharm Therapeutics Inc | Richard Paulson | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 4.54 per share. | 04 Nov 2022 | 3,493 | 616,017 (0%) | 0% | 4.5 | 15,858 | Common Stock |
| Karyopharm Therapeutics Inc | Richard Paulson | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 5.87 per share. | 04 Oct 2022 | 3,488 | 619,510 (0%) | 0% | 5.9 | 20,475 | Common Stock |
| Karyopharm Therapeutics Inc | Richard Paulson | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 5.23 per share. | 08 Sep 2022 | 3,463 | 622,998 (0%) | 0% | 5.2 | 18,111 | Common Stock |
| Karyopharm Therapeutics Inc | Richard Paulson | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 5.25 per share. | 08 Sep 2022 | 16 | 626,461 (0%) | 0% | 5.3 | 84 | Common Stock |
| Karyopharm Therapeutics Inc | Richard Paulson | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 4.48 per share. | 04 Aug 2022 | 2,314 | 626,477 (0%) | 0% | 4.5 | 10,367 | Common Stock |
| Karyopharm Therapeutics Inc | Richard Paulson | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 5.18 per share. | 08 Jul 2022 | 2,115 | 628,791 (0%) | 0% | 5.2 | 10,948 | Common Stock |
| Karyopharm Therapeutics Inc | Richard Paulson | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 5.76 per share. | 07 Jun 2022 | 2,542 | 630,906 (0%) | 0% | 5.8 | 14,642 | Common Stock |
| Karyopharm Therapeutics Inc | Richard Paulson | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 6.23 per share. | 04 May 2022 | 27,869 | 633,448 (0%) | 0% | 6.2 | 173,546 | Common Stock |
| Karyopharm Therapeutics Inc | Richard Paulson | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 6.26 per share. | 04 May 2022 | 633 | 661,317 (1%) | 0% | 6.3 | 3,963 | Common Stock |
| Karyopharm Therapeutics Inc | Richard Paulson | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2022 | 360,000 | 360,000 | - | - | Stock Option (right to buy) | |
| Karyopharm Therapeutics Inc | Richard Paulson | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2022 | 288,750 | 661,950 (1%) | 0% | 0 | Common Stock | |
| Karyopharm Therapeutics Inc | Richard Paulson | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 May 2021 | 559,800 | 559,800 | - | - | Stock Option (right to buy) | |
| Karyopharm Therapeutics Inc | Richard Paulson | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 May 2021 | 373,200 | 373,200 (0%) | 0% | 0 | Common Stock |